CHU de Bordeaux
Bordeaux, France
39 recruiting
Showing 1–20 of 94 trials
Recruiting
Phase 3
Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children
Chronic PainNeuropathic Pain
University Hospital, Brest46 enrolled10 locationsNCT05997979
Recruiting
Not Applicable
The CONFORM Pivotal Trial
Atrial FibrillationStroke
Conformal Medical, Inc1,600 enrolled91 locationsNCT05147792
Recruiting
Phase 2
Early Oxybutinin Treatment for Boys With Posterior Urethral Valves
Male Urogenital Diseases
University Hospital, Bordeaux50 enrolled1 locationNCT04526353
Recruiting
Not Applicable
Management of Bone Loss in Orthopaedic Surgery Using the Masquelet Technique or Transport Nails
Critical-size Bone Defect
University Hospital, Bordeaux250 enrolled1 locationNCT07389681
Recruiting
Not Applicable
Dispensing of Antibiotics in Pharmacies for Cystitis According to a Delegation Protocol, Impact of a Decision Support Tool. PHARIBO: PHarmacy and Resolved Antibiotherapy for Urinary Tract Infections
Acute Cystitis
University Hospital, Bordeaux506 enrolled14 locationsNCT07118748
Recruiting
Not Applicable
Evaluation of A Clinical Diagnostic Test for CRDS
Calcium Release Deficiency Syndrome (CRDS)
Population Health Research Institute400 enrolled19 locationsNCT06188689
Recruiting
International CRDS Registry
Calcium Release Deficiency Syndrome
Population Health Research Institute500 enrolled17 locationsNCT06508164
Recruiting
Phase 1Phase 2
Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors
GliomaCNS Tumor, AdultCNS Tumor, Childhood
Centre Leon Berard70 enrolled12 locationsNCT07243470
Recruiting
Phase 2
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
B-Cell Non-Hodgkins Lymphoma
Hoffmann-La Roche100 enrolled53 locationsNCT06806033
Recruiting
French National Database of Rare Dermatological Cancers
Merkel Cell CarcinomaAdnexal Tumor of SkinAdvanced Basal Cell Carcinoma Requiring Systemic Treatment
University Hospital, Lille9,000 enrolled34 locationsNCT03210935
Recruiting
Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
B-cell Non-Hodgkins Lymphoma (B-NHL)
Regeneron Pharmaceuticals107 enrolled20 locationsNCT05685173
Recruiting
Phase 3
Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients
Acne vulgaris
Centre Hospitalier Universitaire de Nice420 enrolled19 locationsNCT06447480
Recruiting
Phase 2
Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo
Vitiligo
Centre Hospitalier Universitaire de Nice56 enrolled5 locationsNCT07152626
Recruiting
Natural History of Type 1 Interferonopathies: Insights From a European Cohort
Genetic DiseaseAutoimmune DiseasesNeurological Diseases or Conditions+1 more
Imagine Institute500 enrolled32 locationsNCT07040774
Recruiting
Not Applicable
Assessment of the Clinical and Economic Impact of Sim&Size, a Simulation Software for Implantable Devices Used in the Treatment of Intracranial Aneurysms: A Prospective Multicenter Study.
Unruptured Intracranial Aneurysm
Sim&Cure576 enrolled6 locationsNCT07433075
Recruiting
Not Applicable
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
VomitingNausea
Enterra Medical, Inc.148 enrolled22 locationsNCT06464926
Recruiting
Phase 2Phase 3
Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
Chronic Hepatitis D
Mirum Pharmaceuticals, Inc.120 enrolled22 locationsNCT07454837
Recruiting
Phase 2
FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers
CholangiocarcinomaPancreatic Adenocarcinoma
University Hospital, Bordeaux120 enrolled1 locationNCT07478523
Recruiting
Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia
Chronic Lymphocytic LeukemiaBTK Degraders
Nantes University Hospital60 enrolled14 locationsNCT07099443
Recruiting
Phase 1Phase 2
Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia.
Acute Leukemia
Nantes University Hospital21 enrolled4 locationsNCT06356922